US OptionsDetailed Quotes

VRNA240719C25000

Watchlist

0.25
+0.15+150.00%

15min DelayClose Jul 11 15:59 ET

0.38High0.05Low

Verona Pharma Stock Discussion

Xyno

Yesterday 07:38

$Verona Pharma(VRNA.US)$ and finally it seems all brakes are loose and it is going to the top!

Xyno

Jun 27 07:23

$Verona Pharma(VRNA.US)$ Price pressure has begun in pre-market, which looks unreal for a company receicing approval for a novel - and potentially groundbreaking - drug.
Stay calm, dont play in the hands of the shorts. Make sure your stock cannot be borrowed for shorts as well.

Xyno

Jun 27 03:27

Be cautious

$Verona Pharma(VRNA.US)$ shorters will try to push it down. this is a long term hold being a blockbuster drug, with a 2 billion potential further down the road. revenue forecast for this year 40 million. hopefully conference call is giving the price a boost. if a big pharma might do a take over, it goes sky rocketing. whatever it is, don’t sell cheap. Disclaimer: not financial advice.

Trytosaveabit

Jun 26 18:18

News came after close! Note time! Could be hot tomorrow?? NFA Just thinking outloud

$Verona Pharma(VRNA.US)$ Verona Pharma Announces US FDA Approval of Ohtuvayre™ (ensifentrine) 2 HOURS AGO, 4:57 PM EDT VIA GLOBENEWSWIRE: Ohtuvayre is indicated for the maintenance treatment of COPD allowing for broad use in COPD patients First inhaled COPD treatment providing bronchodilation and non-steroidal anti-inflammatory effects Conference call tomorrow at 8:30 a.m. EDT / 1:30 p.m. BST LONDON and RALEIGH,...

71179109

Jun 26 11:07

why going down？

$Verona Pharma(VRNA.US)$

1M的距离

Jun 26 09:37

all in

$Verona Pharma(VRNA.US)$

Meltyy

Jun 25 07:02

🔔 FDA PDUFA Update…

🔥 3 PDUFA decisions this week! 👇
📌 This week’s PDUFAs:
$Merck & Co(MRK.US)$ : 🤔
⇨ Patritumab deruxtecan
‣ Non-small cell lung carcinoma
‣ PDUFA date: 6/26/24 (BLA)
$Verona Pharma(VRNA.US)$ : 🤔
⇨ Ensifentrine (Nebulized)
‣ Chronic obstructive pulmonary disease
‣ PDUFA date: 6/26/24 (NDA)
$Genmab(GMAB.US)$ : 🤔
⇨ EPKINLY® (Epcoritamab)
‣ Follicular lymphoma
‣ PDUFA date: 6/28/24 (sBLA)
🗓️ Last week’s PDUFAs:
$Merck & Co(MRK.US)$ : Approved 6/17 🎉
⇨ CAPVAXIVE (V116)
‣ Pneumo...

Meltyy

Jun 21 01:51

👀 Keep an eye out for the remaining PDUFAs in June! 🔥

$Sarepta Therapeutics(SRPT.US)$ : ELEVIDYS
$Harmony Biosciences(HRMY.US)$ : WAKIX (pitolisant)
$Bristol-Myers Squibb(BMY.US)$ : KRAZATI (Adagrasib) + Cetuximab
$argenx SE(ARGX.US)$ : VYVGART Hytrulo (Efgartigimod)
$Merck & Co(MRK.US)$ : Patritumab deruxtecan
$Verona Pharma(VRNA.US)$ : Ensifentrine (Nebulized)
$Rocket Pharmaceuticals(RCKT.US)$ : KRESLADI (Marnetegragene autotemcel)

Xyno

Jun 19 01:47

The company is 7 days away from a very likely FDA approval which will give them a shot in the arm, dissolving their debt in less than a year when going to market.
This article does not even mention the upcoming approval date and is a sign of incomplete journalism.

Is Verona Pharma (NASDAQ:VRNA) A Risky Investment?

Xyno

Jun 17 08:46

$Verona Pharma(VRNA.US)$ Anyone loading up for June 26 FDA approval date?

No comment yet